Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dihydroquinine
2. Hydroquinidine
3. Hydroquinidine Dihydrochloride, (1beta,4beta,3s)-(+-)-isomer
4. Hydroquinidine Dihydrochloride, (3alpha,9s)-(+-)-isomer
5. Hydroquinidine Hydrochloride
6. Hydroquinidine Monosulfate
7. Hydroquinidine Monosulfate, (1beta,3alpha,4beta,8alpha,9r)-isomer
8. Hydroquinidine Monosulfate, (1beta,3alpha,4beta,9s)-isomer
9. Hydroquinidine Sulfate
10. Hydroquinidine Sulfate, (9s)-isomer
11. Hydroquinidine, (+-)-isomer
12. Hydroquinidine, (1beta, 3alpha,4beta,8alpha,9r)-isomer
13. Hydroquinidine, (1beta,3alpha,4beta,9s)-isomer
14. Hydroquinidine, (1beta,4beta,9s)-(+-)-isomer
15. Hydroquinidine, (3alpha,9s)-(+-)-isomer
16. Hydroquinidine, (8alpha,9r)-isomer
17. Hydroquinidine, (8alpha,9s)-isomer
18. Hydroquinidine, (9r)-isomer
19. Hydroquinidine, (9s)-(+-)-isomer
20. Hydroquinine
21. Lcn 834
22. Lcn-834
23. Lentoquine
24. Srcor
1. Hydroquinidine
2. 1435-55-8
3. Hydroconquinine
4. Hydroconchinine
5. Dihydroquinine
6. (+)-hydroquinidine
7. (9s)-10,11-dihydro-6'-methoxycinchonan-9-ol
8. 8p68xpy4hg
9. Dihydrochinidin
10. 10,11-dihydroquinidine
11. Mfcd00135599
12. Cinchonan-9-ol, 10,11-dihydro-6'-methoxy-, (9s)-
13. (s)-((1s,2r,4s,5r)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methanol
14. (+)-dihydroquinidine
15. Einecs 215-862-5
16. Gnf-pf-2067
17. Unii-8p68xpy4hg
18. Hydroquinidine, 95%
19. Hydroquinidine [mi]
20. Schembl308961
21. (8r,9s)-10,11-dihydro-6'-methoxy-9-cinchonanol
22. Chembl531472
23. Megxp0_001892
24. Hydroquinidine [who-dd]
25. Acon1_001481
26. Dtxsid50862110
27. Act08913
28. Zinc3977899
29. S4648
30. S4658
31. Ccg-267773
32. Ccg-267774
33. Db15300
34. Nsc 757410
35. Ncgc00180461-01
36. Ncgc00180461-02
37. Ncgc00385753-01
38. (+)-dihydroquinidine, Analytical Standard
39. As-16052
40. A20646
41. Fmoc-(s)-3-amino-4-(2-naphthyl)butanoicacid
42. 435h558
43. Q5276449
44. Brd-k98182306-001-01-3
45. (9s)-10,11-dihydro-6'-methoxycinchonan-9-ol;hydroquinidine
46. (s)-((2r,4s,5r)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methanol
Molecular Weight | 326.4 g/mol |
---|---|
Molecular Formula | C20H26N2O2 |
XLogP3 | 3.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 4 |
Exact Mass | 326.199428076 g/mol |
Monoisotopic Mass | 326.199428076 g/mol |
Topological Polar Surface Area | 45.6 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 432 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
C - Cardiovascular system
C01 - Cardiac therapy
C01B - Antiarrhythmics, class i and iii
C01BA - Antiarrhythmics, class ia
C01BA13 - Hydroquinidine
ABOUT THIS PAGE
A Hydroconchinine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hydroconchinine, including repackagers and relabelers. The FDA regulates Hydroconchinine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hydroconchinine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Hydroconchinine supplier is an individual or a company that provides Hydroconchinine active pharmaceutical ingredient (API) or Hydroconchinine finished formulations upon request. The Hydroconchinine suppliers may include Hydroconchinine API manufacturers, exporters, distributors and traders.
Hydroconchinine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hydroconchinine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hydroconchinine GMP manufacturer or Hydroconchinine GMP API supplier for your needs.
A Hydroconchinine CoA (Certificate of Analysis) is a formal document that attests to Hydroconchinine's compliance with Hydroconchinine specifications and serves as a tool for batch-level quality control.
Hydroconchinine CoA mostly includes findings from lab analyses of a specific batch. For each Hydroconchinine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hydroconchinine may be tested according to a variety of international standards, such as European Pharmacopoeia (Hydroconchinine EP), Hydroconchinine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hydroconchinine USP).
LOOKING FOR A SUPPLIER?